
With a mifepristone safety review due by March and Senate control shifting in January, the FDA faces an extended stretch without a permanent leader.
September highlights Blood Cancer Awareness Month, focusing on education, early diagnosis, and support for multiple myeloma, lymphoma, and leukemia patients.
September is Blood Cancer Awareness Month, an observance dedicated to raising awareness about blood cancers, such as multiple myeloma (MM), lymphoma, and leukemia. This month is focused on spreading information about signs and symptoms and encouraging early diagnosis, as well as garnering support for critical research and affected patients and their families.






